These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 37464766)

  • 1. Mixture-Based Screening of Focused Combinatorial Libraries by NMR: Application to the Antiapoptotic Protein hMcl-1.
    Alboreggia G; Udompholkul P; Baggio C; Pellecchia M
    J Med Chem; 2023 Jul; 66(14):10108-10118. PubMed ID: 37464766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and characterization of a functional library for NMR screening against novel protein targets.
    Mercier KA; Germer K; Powers R
    Comb Chem High Throughput Screen; 2006 Aug; 9(7):515-34. PubMed ID: 16925512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of small molecule libraries for NMR screening and other applications in drug discovery.
    Jacoby E; Davies J; Blommers MJ
    Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery.
    Wu B; Zhang Z; Noberini R; Barile E; Giulianotti M; Pinilla C; Houghten RA; Pasquale EB; Pellecchia M
    Chem Biol; 2013 Jan; 20(1):19-33. PubMed ID: 23352136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of 19F NMR spectroscopy to screen chemical libraries for ligands that bind to proteins.
    Tengel T; Fex T; Emtenas H; Almqvist F; Sethson I; Kihlberg J
    Org Biomol Chem; 2004 Mar; 2(5):725-31. PubMed ID: 14985813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Object-oriented approach to drug design enabled by NMR SOLVE: first real-time structural tool for characterizing protein-ligand interactions.
    Sem DS; Yu L; Coutts SM; Jack R
    J Cell Biochem Suppl; 2001; Suppl 37():99-105. PubMed ID: 11842434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-Directed Dynamic Combinatorial Chemistry: A Guide to Protein Ligand and Inhibitor Discovery.
    Huang R; Leung IK
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for high-throughput assay development using leads derived from nuclear magnetic resonance-based screening.
    Hajduk PJ; Betz SF; Mack J; Ruan X; Towne DL; Lerner CG; Beutel BA; Fesik SW
    J Biomol Screen; 2002 Oct; 7(5):429-32. PubMed ID: 14599358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMR fragment screening: tackling protein-protein interaction targets.
    Schade M; Oschkinat H
    Curr Opin Drug Discov Devel; 2005 May; 8(3):365-73. PubMed ID: 15892252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of affinities of ligands in mixtures via magnetic recovery of target-ligand complexes and chromatographic analyses: chemometrics and an experimental model.
    Yang X; Xie Y; Pu J; Zhao H; Liao J; Yuan Y; Zhu S; Long G; Zhang C; Yuan H; Chen Y; Liao F
    BMC Biotechnol; 2011 May; 11():44. PubMed ID: 21545719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seamless bead to microarray screening: rapid identification of the highest affinity protein ligands from large combinatorial libraries.
    Astle JM; Simpson LS; Huang Y; Reddy MM; Wilson R; Connell S; Wilson J; Kodadek T
    Chem Biol; 2010 Jan; 17(1):38-45. PubMed ID: 20142039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR-based screening methods for lead discovery.
    Vogtherr M; Fiebig K
    EXS; 2003; (93):183-202. PubMed ID: 12613177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists.
    Wu B; Barile E; De SK; Wei J; Purves A; Pellecchia M
    Curr Top Med Chem; 2015; 15(20):2032-42. PubMed ID: 25986689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical aspects of NMR-based fragment discovery.
    Zartler ER; Mo H
    Curr Top Med Chem; 2007; 7(16):1592-9. PubMed ID: 17979770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate scaffolds in chemical genetic studies.
    Nicotra F; Cipolla L; La Ferla B; Airoldi C; Zona C; Orsato A; Shaikh N; Russo L
    J Biotechnol; 2009 Nov; 144(3):234-41. PubMed ID: 19539677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method for quantitative protein-ligand affinity measurements in compound mixtures.
    Annis DA; Shipps GW; Deng Y; Popovici-Müller J; Siddiqui MA; Curran PJ; Gowen M; Windsor WT
    Anal Chem; 2007 Jun; 79(12):4538-42. PubMed ID: 17500537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient Screening of Target-Specific Selected Compounds in Mixtures by
    Vulpetti A; Lingel A; Dalvit C; Schiering N; Oberer L; Henry C; Lu Y
    ChemMedChem; 2022 Jul; 17(13):e202200163. PubMed ID: 35475323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A straightforward NMR-spectroscopy-based method for rapid library screening.
    Siriwardena AH; Tian F; Noble S; Prestegard JH
    Angew Chem Int Ed Engl; 2002 Sep; 41(18):3454-7. PubMed ID: 12298062
    [No Abstract]   [Full Text] [Related]  

  • 19. Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design.
    Moore J; Abdul-Manan N; Fejzo J; Jacobs M; Lepre C; Peng J; Xie X
    J Synchrotron Radiat; 2004 Jan; 11(Pt 1):97-100. PubMed ID: 14646145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Library design for fragment based screening.
    Schuffenhauer A; Ruedisser S; Marzinzik AL; Jahnke W; Blommers M; Selzer P; Jacoby E
    Curr Top Med Chem; 2005; 5(8):751-62. PubMed ID: 16101415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.